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ONLINE SUPPLEMENTARY MATERIAL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A1.    Cardiac functional analysis by cine MRI  
  +/Y (n=14)  -/Y (n=16) p value* 
Body weight, g 32.7 ± 1.0 31.1 ± 0.9 n.s. 
Heart rate, bpm 519 ± 14 540 ± 10 n.s. 
Age, days 130 ± 6 132 ± 7 n.s. 
EDV, µl 67.7 ± 1.8 57.4 ± 2.2 < 0.01 
ESV, µl 23.2 ± 1.2 16.9 ± 1.5 < 0.01 
SV, µl 44.5 ± 1.4 40.4 ± 1.0 < 0.05 
EF, % 66 ± 1 71 ± 2 < 0.05 
CO, ml/min 23.1 ± 0.9 21.8 ± 0.6 n.s. 
LVM, mg 106.0 ± 1.8 102.2 ± 2.6 n.s. 
* two-tailed unpaired Student’s t-test 
 
 
 
 
 
Table A2: PV Haemodynamic data 
    
+/Y (n=4) 
    
-/Y (n=6) 
    p value*   
  Baseline Dobutamine ∆ Baseline Baseline Dobutamine ∆ Baseline Baseline Dobutam
ine 
∆ 
Baseline 
Corrected 
ESP (mmHg) 
91.1 ± 4.2 89.1 ± 4.6 -2.1 ± 2.3 95.5 ± 2.8 93.3 ± 3.3 -2.2 ± 2.8 
1 0.201 1 
Corrected 
EDP (mmHg) 
5.0 ± 1.7 5.4 ± 1.5 0.4 ± 1.6 4.6 ± 1.7 5.8 ± 2.1 1.2 ± 0.8 
0.670 0.286 0.762 
Heart Rate 
(BPM) 
467.1 ± 44.9 539.2 ± 38.2 72.1 ± 19.7 493.0 ± 25.2 557.9 ± 34.4 64.9 ± 14.1 
0.522 0.394 0.61 
Max dP/dt 
(mmHg/s) 
8643.2 ± 
660.1 
11300.8 ± 
1172.4 
2657.6 ± 
654.4 
9798.3 ± 
751.5 
11210.47 ± 
1045.64 
1412.2 ± 
758.5 0.054 0.831 0.114 
Min dP/dt 
(mmHg/s) 
-6689.9 ± 
1213.9 
-6895.8 ± 
1390.0 
-205.9 ± 
542.8 
-7992.1 ± 
376.1 
-8001.2 ± 
432.0 
-9.1 ± 
393.3 0.286 0.522 0.352 
Tau (ms) 7.40 ± 1.0 6.48 ± 1.0 -0.92 ± 0.4 6.4 ± 0.8 5.9 ± 0.7 -0.5 ± 0.5 0.088 1 0.114 
Means ± SD 
* Exact significance, Mann-Whitney test 
 
 
 Table A3. Left 
Ventricular 
Segmentation     
Segment p value 
1. basal anterior 0.54 
2. basal anteroseptal 0.03* 
3. basal inferoseptal 0.93 
4. basal inferior 0.43 
5. basal inferolateral 0.12 
6. basal anterolateral  0.52 
7. mid anterior 0.04* 
8. mid anteroseptal 0.19 
9. mid inferoseptal 0.8 
10. mid inferior 0.53 
11. mid inferolateral 0.22 
12. mid anterolateral 0.02* 
13. apical anterior 0.16 
14. apical septal 0.04* 
15. apical inferior 0.39 
16. apical lateral  0.37 
F test to compare variances of +/Y vs -/Y 
 
 
 
 
 
 
 
 
 
 
 
Table A4: Left ventricular functional indices during Dobutamine stress 
    +/Y  (n=4)     -/Y  (n=6)     
  Baseline Dobutamine ∆ Baseline Baseline Dobutamine ∆ Baseline 
p 
value* 
heart rate [bpm] 505±58 549±23 87 ± 58 549±23 584±7 35 ± 25 0.082 
EDV (slice) [µl] 9.85±0.77 8.22±1.14 -1.64±0.95 10.03±1.69 8.76±1.31 -1.24 ± 0.76 0.730 
ESV (slice) [µl] 2.84±0.75 0.79±0.43 -2.05±0.48 1.84±1.04 0.85±0.49 -0.98 ± 0.69 0.114 
EF  [%] 71.4±5.42 90.71±4.08 19.31±3.06 81.87±8.22 90.02±5.07 8.15 ±5.78 0.029 
PER [ml/sec] -0.25±0.03 -0.30±0.04 -0.06±0.02 -0.32±0.06 -0.34±0.04 -0.02 ± 0.04 0.200 
PFR [ml/sec] 0.28±0.03 0.30±0.03 0.02±0.02 0.28±0.03 0.32±0.09 0.04 ± 0.07 0.730 
Mean EDWT [mm] 0.98±0.10 1.07±0.18 0.09±0.09 1.02±0.09 1.07±0.07 0.04 ± 0.04 0.556 
Mean ESWT [mm] 1.45±0.18 2.01±0.20 0.56±0.26 1.81±0.33 2.03±0.19 0.22 ± 0.17 0.114 
Means ± SD 
PER: Peak Ejection Rate; PFR: Peak Filling Rate; EDWT: End-diastolic wall thickness;  ESWT: End-systolic wall 
thickness.  
* Exact significance, Mann-Whitney test, ∆ Baseline +/Y vs -/Y 
 
      
Table A5: Left ventricular function during Esmolol treatment  
    +/Y  (n=9)     -/Y  (n=9)     p value   
  Baseline Esmolol ∆ Baseline Baseline Esmolol ∆ Baseline Baseline‡ Esmolol‡ 
∆ 
Baseline* 
heart rate 
[bpm] 527 ± 54 460 ± 41 -67 ± 10 536 ± 49 446 ± 23 -91 ± 12 1 1 0.11 
EDV [µl] 71.3 ± 3.5 84.9 ± 6.6 13.7 ± 1.7 60.0 ± 9.4 75.1 ± 4.1 15.2 ± 2.3 0.015 0.004 0.73 
ESV [µl] 24.0 ± 4.9 39.9 ±7.6 15.8 ± 1.8 18.3 ± 7.3 33.4 ± 3.3 15.2 ± 1.7 0.182 0.304 0.86 
SV [µl] 47.2 ± 3.5 45.1 ± 3.3 -2.1 ± 0.8 41.7 ± 2.7 41.7 ± 1.4 0.0 ± 0.9† 0.109 0.002 0.05 
EF [%] 66 ± 6 53 ± 6 -13 ± 1 71 ± 8 56 ± 2 -15 ± 2 1 0.796 0.6 
CO [ml/min] 24.8 ± 2.1 20.7 ± 1.3 -4.1 ± 0.6 22.2 ± 1.9 18.6 ± 1.2 -3.6 ± 0.4 0.071 0.013 0.26 
Means ± SD 
‡ ANOVA with Bonferroni correc@on, +/Y vs -/Y  
† By ANOVA (Bonferroni correction), Baseline vs Esmolol was p<0.05 for all +/Y and -/Y parameters, except SV 
* Exact significance, Mann-Whitney test, ∆ Baseline +/Y vs -/Y 
 Table A6: Echocardiographic Measurements  
  +/Y (n=3) -/Y (n=6)   
  Mean SD Mean SD p value* 
A' -12.90 1.05 -10.96 2.55 0.71 
E' -19.36 1.08 -17.52 3.69 0.91 
MV A 342.88 94.90 426.39 65.42 0.38 
MV E 617.63 160.21 777.26 54.44 0.17 
            
A'/E' 0.67 0.05 0.63 0.11 1.00 
E'/A' 1.50 0.11 1.63 0.33 1.00 
MV E/A 1.81 0.14 1.87 0.42 0.71 
MV E/E' -32.12 9.28 -45.43 16.76 0.17 
 Means ± SD 
* Exact significance, Mann-Whitney test 
 
 
Extended Materials and Methods 
 
Global Tβ4 KO mice 
As previously described [26], the Tβ4 gene targeting vector was created by ligating a 6.5kb fragment 
containing a 5’arm (exon 1; BamHI-EcoRV) and 3’ arm (exon 3; Nhe1-BamH1) flanking a neomycin 
resistance cassette, thereby deleting exon 2 of the Tmsb4x gene. The construct was linearised and 
electroporated into ES cells which were subject to positive-negative selection and screening by 
Southern blot analysis for homologous recombination using 5’ flanking and internal probes. Male 
chimaeras were generated from targeted ES cell lines and F1 mice generated by crossing to wild type 
C57Bl6/J females. Progeny were genotyped using a PCR that amplifies both mutant and wild type 
alleles. Mice have been maintained on a C57Bl6/J background for more than 25 generations.  
Experiments were performed on 14-19 week old mice except, as indicated, for developmental time 
course data. 
MR Image acquisition 
Mice were anaesthetised with isoflurane (4%) and placed onto an animal cradle in supine position. 
Animals were kept at 37±1 °C (during image acquisition) via a water- and air- heating system while 
oxygen and anaesthetics (1-2% isoflurane) were supplied via a nose cone (1 L/min). A neonatal apnoea 
sensor was placed on the abdomen for respiratory gating. Electrocardiogram (ECG) was obtained by 
needle electrodes inserted subcutaneously into the forelimbs. For Dobutamine and Esmolol stress tests 
an intraperitoneal (i.p.) infusion line was prepared and connected to an infusion pump (PHP2000 
Harvard Instruments, UK). Image acquisition was performed with a 39 mm diameter volume coil (Rapid 
Biomedical GmbH, Germany). Cardio-respiratory monitoring and gating were performed using an MR-
compatible system (SA Instruments, NY).  
Imaging was performed using a 9.4T VNMRS horizontal bore scanner (Agilent Technologies, 
CA) with a shielded gradient system (1000 mT/m). Long and short axis scout images were acquired to 
define the two and four chamber long axis view. The cine long axis views were used to define the short 
axis orientation. An ECG and respiratory gated spoiled gradient echo (GE) sequence was used to acquire 
cine cardiac images with the following parameters for standard cine acquisitions: TE 1.18 ms, TR 4.5 
ms, flip angle 15°, slice thickness 1 mm, no slice separation, FOV 25.6×25.6 mm², matrix size 128×128, 
NSA 2. Twenty cine-frames were recorded to cover the cardiac cycle. A single short-axis slice was 
obtained in approximately 55 seconds, leading to a total scan time of around 9 to 11 minutes covering 
the apex to base (10-12 slices).  
In order to assess the filling and discharging pattern of the left ventricle at baseline or under 
Dobutamine stress, a mid-ventricular short-axis slice was selected and images were acquired with a 
short TR using the following imaging parameters: TE 1.07 ms, TR 2.4 ms, flip angle 10°, slice thickness 
1 mm, FOV 25.6×25.6 mm², matrix size 128×128, NSA 2. Sixty-two cine-frames were recorded to 
cover approximately 1.5 cardiac cycles. After the acquisition of the baseline images, i.p. infusion of 
Dobutamine was started at 40 µg kg-1 min-1. Image acquisition under Dobutamine stress was started 
after the heart rate had increased by approximately 10% (10-15 minutes). 
In order to assess the effect of the β-blocker Esmolol, a full stack of baseline cine images were 
acquired before i.p. Esmolol infusion was started at 5 mg kg-1 min-1. A reduction in heart rate by 
approximately 80 beats per minute within 5-7 minutes was observed. When the heart rate had stabilised, 
a full cine stack, including long axis views, was acquired using the same imaging parameters as for 
standard cine (see above). 
MR Image analysis 
Short and long axis images for each animal were combined into one dataset, randomised and 
anonymised. Images were analysed as previously described [27], using the cardiac analysis software 
Segment (http://segment.heiberg.se). Briefly, short axis images were automatically segmented with the 
LV tool of Segment followed by manual adjustments where necessary. Papillary muscles were 
segmented as circular objects surrounded by blood on short-axis slices at end-diastole and treated as 
myocardium. When papillary muscles were pressed against the endocardial wall at end-systole, they 
were segmented as myocardium by including them within the endocardial border, as previously 
described [27]. End diastolic volume (EDV) and end systolic volume (ESV) were identified by the 
global maximum and minimum LV cavity volume respectively. The left ventricular mass (LVM) was 
calculated as the difference between epicardial and endocardial volume at end diastole multiplied by 
1.05 g/ml. Other parameters were calculated as follows: Stroke volume (SV) = EDV – ESV; Ejection 
fraction (EF) = 100 * SV / EDV; Cardiac output (CO) = SV * heart rate. Papillary muscles were treated 
as myocardium for all volume measurements, except when generating Bulls eye plots where papillary 
muscles were treated as part of the blood pool. The Bulls eye plots were generated with Segment 
following the AHA convention. 
The mid-ventricular cine images with higher temporal resolution for rest and Dobutamine stress 
were randomised and anonymised. Images were automatically segmented using Segment with manual 
corrections for papillary muscles if necessary. Peak ejection rate (PER) and peak filling rate (PFR) were 
calculated from the maximum change in blood volume (dV/dt) using a moving average over two values.  
 
Echocardiographic and haemodynamic assessment of function 
Echocardiograms were obtained in male +/Y and -/Y mice at 17-18 weeks of age by a single operator. 
Mice were anaesthetised with 4 % isoflurane in medical oxygen and maintained at 1–1.5 % by nose-
cone on a homeothermic platform. Chest fur was shaved for imaging with a Visualsonics Vevo 2100 
using a 22–55 MHz transducer. Pulse wave Doppler measurements were obtained across the mitral 
valve via the apical 4-chamber view and tissue Doppler imaging for radial velocities via a parasternal 
short-axis view. Haemodynamic measurements were performed on the same mice 3-4 days later under 
identical anaesthetic conditions. The LV was cannulated via the right carotid artery using a 1.4-F Millar 
Mikro-Tip cannula (SPR-839, Millar Instruments, Houston, Texas). The right jugular vein was 
cannulated with stretched polyethylene tubing for infusion of dobutamine hydrochloride (16 µg kg-1 
min-1) to test contractile reserve. Measurements were obtained after 15 min of equilibration via a 
Powerlab 4SP data acquisition system (ADInstruments, UK). All data acquisition and analysis was 
performed blind to genotype. 
 
Force-Ca2+ sensitivity measurement 
Solution compositions for force-Ca2+ sensitivity measurements were determined using an iterative 
computer program that uses published affinity constants[28] to calculate the equilibrium concentration 
of ligands and ions. Solutions contain (in mmol L-1): 80 MOPS, 15 EGTA, 1 Mg2+, 5 MgATP, 135 
(Na+ + K+), 15 creatine phosphate and 20 units ml-1 creatine phosphokinase, pH 7.0 (at 15°C). Ca2+ 
concentration was varied using CaCl2. Total ionic strength was 170 mmol L-1. Mice were killed via 
cervical dislocation. Hearts were rapidly excised and dissected in oxygenated physiological salt 
solution. Left ventricular trabeculae (width: 80-250 µm, length: 1.0-3.0 mm) were cut and washed 
overnight at 4°C in relaxing solution containing 1 % Triton X-100. After skinning, fibres were stored 
in 50% glycerol relaxing solution at -20 °C for experiments within 1 week. Skinned trabeculae were 
assessed using an Aurora Scientific Permeabilized Fibre Test System. Sarcomere length was set at 2.0 
µm in relaxing solution using laser diffraction and experiments were conducted at 15 °C. Isometric 
force was measured by transiently shortening the fibre to slack length. Passive force, measured in 
relaxing solution, was subtracted from total force at each Ca2+ concentration to determine active force. 
 
Adult Cardiomyocyte isolation 
Murine left ventricular myocytes were isolated using an enzymatic digestion technique. The heart was 
submitted to retrograde perfusion with a Ca2+-free buffer for 3 minutes followed by a 1mg/ml 
Collagenase type II solution (250 units/mg, Worthington Biochemical Corporation) for 9 minutes. The 
digested tissue was mechanically agitated in enzymatic solution for an additional 5 minutes and the 
cells were collected by centrifugation at 500 rpm.  
 
Functional assessment of cardiomyocytes 
Functional assessment of the isolated cardiomyocytes was conducted within 6 hours of isolation using 
an IonOptix-µStep Myocyte Contractility System. Fractional shortening was assessed via Fast Fourier 
Transform-based sarcomere length tracking. [Ca2+] transients were measured in cells loaded with 1mM 
Fura-2-AM (Life Technologies) and 2µM Pluronic. 
 
Immunohistochemistry and sarcomere length determination 
Imaging of fixed cardiomyocytes was performed using a Leica TCS SP5 II system. Leica Application 
Suite (LAS) AF Lite was used to measure image intensity over a line segment drawn perpendicular to 
visible striations. Matlab was used to locate peaks in the intensity plot and calculate the associated 
difference between peaks. The mean difference between peaks for each cell was considered its 
sarcomere length. 
 
Embryonic Cardiomyocyte Culture 
Primary cultures of cardiomyocytes were prepared from WT or Tβ4 KO E18.5 mouse hearts, essentially 
as previously described for neonatal cardiomyocytes[29],  and cultured at an initial density of 1 × 106 
cells per well in a 6-well plate (with gelatin-coated coverslips for immunofluorescence analysis). 
Cardiomyocytes were >95% pure at time of plating as determined by immunofluorescence detection of 
cardiac sarcomeric markers. After overnight culture in plating medium, cells were washed twice in PBS 
and medium replaced with maintenance medium (4:1 DMEM:M199; 1% FBS) containing either PBS 
(vehicle control) or Tβ4 (100ng/ml, a kind gift from RegeneRx Pharmaceuticals). Medium, 
supplemented with fresh Tβ4 or PBS, was changed daily. Cells were harvested after 1, 5 and 9 days for 
real time qPCR and immunofluorescence analysis.  
 
Immunodetection Methods 
Immunofluorescence was performed on cryosections of diastole-fixed mouse hearts or on soleus or 
tibialis anterior muscle from mice at various developmental stages and on embryonic murine 
cardiomyocytes using standard protocols with the following antibodies: sarcomeric α-actinin (SαA; 
Sigma), Thymosin β4 (Immundiagnostik), myomesin and cardiac myosin binding protein C (cMyBPC 
a kind gift of Elisabeth Ehler/ Mathias Gautel), cTnT and cTNI, (Abcam); N2B, PEVK or N2A (kind 
gifts of Siegfried Labeit). Images were acquired using either an Olympus  IX81 microscope, a Zeiss 
AxioImager with ApoTome or a Leica DM6000 fluorescence microscope with Structured Illumination.   
 
Thin Filament and Sarcomere Length Measurements on Sectioned Left Ventricle 
Hearts were fixed in diastole by injection of 100mM KCl into the left atrium of mice while anaesthetised 
with isoflurane. After rapid arrest in diastole, 4% PFA in phosphate buffered saline (PBS) was perfused 
for 2-3 minutes before hearts were removed and incubated in the same fixative for a further 2 hours. 
After washing with PBS and embedding in Tissue-Tek O.C.T. compound, hearts were rapidly chilled 
in isopentane, within a dry ice bath. 7µm thick sections were prepared and stained, as described above. 
Confocal images were obtained using an Olympus IX81 confocal microscope (6 left ventricular fields 
of view per section from 3 sections at different levels through the heart, from 5 -/Y and 3 +/Y hearts). 
Images were analysed in ImageJ (http://rsb.info.nih.gov/ij), with 1D plot profiles drawn along the 
myofibril, perpendicular to the Z-lines. Well-defined peaks were obtained, as shown in Fig. 2T, in which 
major peaks represented α-actinin positive Z-lines and minor peaks represented Tmod-1 positive thin 
filament ends. Sarcomere length (SL) was measured as the distance between 2 α-actinin peaks (at their 
centres, via a perpendicular line) and TFL as the distance between an α-actinin peak and a Tmod1 peak. 
 
Histological Methods 
Sections of adult heart were stained with hematoxylin and eosin, using a standard protocol, or Alexa 
594-conjugated wheatgerm agglutinin (Invitrogen), according to the manufacturer’s instructions. 
Nuclear counts, cell area and cell counts were performed on sections which had been anonymised and 
blinded for genotype, using ImageJ software particle analysis. 
 
Analysis of titin isoforms by SDS-PAGE 
Hearts were homogenized in sample buffer containing 8 M urea, 2 M thiourea, 3% SDS, 75 mM DTT, 
10% glycerol, bromophenol blue and 0.05 M Tris·HCl, pH 6.8 (samples prepared as described in[23]). 
Samples were incubated for 5 min on ice and boiled for 5 min at 95°C, followed by centrifugation. 
Agarose-strengthened SDS-PAGE (2% polyacrylamide; 0.5% agarose) was performed, at 2mA 
overnight, and protein bands were visualized, following Coomassie brilliant blue staining, and scanned 
using a ChemiDoc system (BioRad). Densitometry analysis was performed using ImageJ to determine 
relative intensities and % total titin. 
 
RNA isolation and gene expression profile by real time qRT-PCR 
Total RNA was isolated from the ventricles of collected hearts using Trizol reagent (Invitrogen) or from 
embryonic murine cardiomyocytes using the RNeasy Plus Micro kit (Qiagen), according to the 
manufacturer's instructions, and reverse-transcribed using Superscript III RT (Invitrogen). Real-time 
RT-PCR analysis was performed on an ABI 7900 Sequence Detector using SYBR Green (Applied 
Biosystems). Data were normalised to Hprt1 expression (endogenous control). Fold-changes in gene 
expression were determined by the 2−ΔΔCT method [30].  
 
Real time qRT-PCR Primers 
N2A  F: GCAAGCACGAAGACCTCGAA 
(Ex 107-108) R: CGAAAGTAGCAGACTGATGCTC 
N2B  F: CTGCAAAGCCTCCAATGAGT 
(Ex 50-219)    R: TTTCAGCACCACCTCTTCCT 
Myh7   F: ACTGTCAACACTAAGAGGGTCA 
R: TTGGATGATTTGATCTTCCAGGG 
Nppa  F: TTCCTCGTCTTGGCCTTTTG 
  R: CCTCATCTTCTACCGGCATCTTC 
Nppb  F: GAGGTCACTCCTATCCTCTGG 
  R: GCCATTTCCTCCGACTTTTCTC 
Srsf1  F: TCTCACGAGGGAGAAACTGC   
R: CTGCTACGGCTTCTGCTACG 
Srsf2  F: CGCGCTCCAGATCAACCTC   
  R: CTTGGACTCTCGCTTCGACAC 
Srsf3  F: GCGCAGATCCCCAAGAAGG   
  R:  ATCGGCTACGAGACCTAGAGA 
Srsf5  F: AGGACGATACTCCGACCGTTT   
  R: GCAAAGGTTACTTCCCCAGC 
Srsf6  F: CAAAAATGGGTACGGTTTCGTG   
  R: AGTTCTCCGACTGCTGTATCC 
Srsf7  F: AGGACGGAGGTCAAGATCAG   
  R: GGGGAACGACTTCTTTTAGGAGA 
Sf3b1   F: GTGGGCCTTGATTCCACAGG 
R: GGCTTCTTCTGACCGAGCAA 
Sfpq  F: TGTCGGTTGTTTGTGGGGAAT   
  R: AACCCGAACCCTTTGCCTTT 
Rbm20  F: CCTGCCTTTGGGTCTCGGCTTAAC 
  R: CCCTTTCACATGTAGCTCCCAGTC 
Hprt1  F: TCAGTCAACGGGGGACATAAA 
  R: GGGGCTGTACTGCTTAACCAG 
 
Statistical analysis 
For the comparison of LV baseline data, a two-tailed unpaired Student’s t-test was used to determine 
any significant differences (P < 0.05). The requirements for a t-test were assessed using a Shapiro-Wilk 
test for normality and an F-Test to compare the variances. For the comparison of functional indices at 
rest and under Esmolol treatment, a two-way ANOVA with Bonferroni correction was used. 
Dobutamine MRI, ECHO and haemodynamic data were analysed using a two-tailed Mann–Whitney 
test with multiple correction.  Statistical analysis was performed using R software version 2.8.1 or SPSS 
22.  
 
Fig. A1 
 
 
 
 
Cardiomyocytes from Tβ4 null mice exhibit no significant differences in shortening or Ca2+ 
handling parameters. Averaged shortening (A) and Ca2+ transient (B) traces at 6Hz stimulation 
frequency from cardiomyocytes isolated from control (+/Y, black) and Tβ4 null (-/Y, red) mice were 
broadly similar. No consistent significant differences were detected in fractional shortening (C) or Ca2+ 
transient magnitudes (D) across all stimulation frequencies. (n=55 +/Y and 63 -/Y; Sarcomere length = 
1.76 +/- 0.01µm (+/Y); 1.63 +/- 0.03µm (-/Y; p=0.01). 
 
 
 
Fig. A2 
 
Shortened sarcomere length in skeletal muscle from Tβ4 knockout mice. Representative 
longitudinal sections of Soleus muscles from Tβ4 -/Y mice (n=5) and +/Y controls (n=3). Closer 
apposition of Z- and M- bands was revealed with dual myomesin/phalloidin staining (A +/Y vs B -/Y); 
shortened titin was confirmed by the reduced spacing of the N2A element (C +/Y vs D -/Y).  
 
 
Fig. A3 
 
 
Cellular compartmentalisation of endogenous and exogenous Tβ4. In WT cardiomyocytes, Tβ4 
localises throughout the cytoplasm and the nucleus and binds not only to G-actin but also to actin 
filaments (A, showing co-localisation with phalloidin-stained F-actin, and B). As expected, no Tβ4 
expression is detected in KO cardiomyocytes (E, F). Upon addition of exogenous Tβ4, either to WT or 
KO cardiomyocytes (C, D and G, H, respectively), Tβ4 binds filamentous actin and strikingly 
accumulates in and around the nucleus. 
 
 
 
Fig. A4 
 
 
Serine/arginine-rich splicing factors (SRSFs) are mis-regulated in postnatal Tβ4 -/Y hearts. qRT-
PCR revealed SRSFs 1, 2, 3 and 7 and SFPQ were up-regulated whereas SRSF5 was down-regulated, 
in postnatal Tβ4 -/Y hearts, shown at P21. Expression of RBM20 was not significantly altered. *: 
p<0.05; **: p<0.01; ***:p<0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legends for Video Files 
Video 1 
High temporal resolution cine-MRI to assess global functional and morphological parameters in 
+/Y (WT) and -/Y (KO) mice. Significantly reduced left ventricular end-diastolic volumes in -/Y mice 
are apparent, shown here in mid-ventricular short axis (KO1, middle panel, compared with WT, left 
panel).  Distinct regional variability in % fractional wall thickening was apparent in -/Y hearts, 
consistent with the patchy distribution of cardiomyocytes with shorter sarcomeres. Variability in wall 
motion contributed to a more pronounced twisting motion in -/Y hearts upon contraction (particularly 
evident in KO2, right panel). 
 
Video 2 
Τβ4 knockout mice subjected to dobutamine stress testing, with high temporal cine MR imaging.  
The inotropic effects of dobutamine increase cardiac output via elevated heart rate and enhanced 
myocardial contractility. +/Y control mice (WT) decreased ESV with dobutamine treatment, as 
evidence of a normal contractile reserve. In contrast, -/Y (KO) mice already display small ESV at 
baseline, and this is only modestly reduced by dobutamine treatment. This test reveals that Tβ4 -/Y 
mice possess a limited contractile reserve.  
 
Video 3 
Tβ4 -/Y mice depend upon increasing heart rate and ejection fraction to maintain an effectively 
normal cardiac output. Bolus infusion of the β1-selective antagonist esmolol slowed heart rate and 
increased LV volumes in both +/Y (WT) and -/Y (KO) hearts. Whereas esmolol treatment markedly 
reduced SV in WT mice, KO mice were unaffected; cardiac output dropped significantly in KO mice.   
 
